Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes

The greater odds of initiating insulin during the 6 months prior to diagnosis of upper GI cancers suggest reverse causation. After cancer diagnosis, drops in use of GLDs was commonly seen.